GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LabGenomics Co Ltd (XKRX:084650) » Definitions » Piotroski F-Score

LabGenomics Co (XKRX:084650) Piotroski F-Score : 2 (As of Dec. 14, 2024)


View and export this data going back to 2013. Start your Free Trial

What is LabGenomics Co Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

LabGenomics Co has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for LabGenomics Co's Piotroski F-Score or its related term are showing as below:

XKRX:084650' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 8
Current: 2

During the past 12 years, the highest Piotroski F-Score of LabGenomics Co was 8. The lowest was 2. And the median was 4.


LabGenomics Co Piotroski F-Score Historical Data

The historical data trend for LabGenomics Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LabGenomics Co Piotroski F-Score Chart

LabGenomics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 8.00 5.00 5.00 2.00

LabGenomics Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 2.00 2.00 2.00 2.00

Competitive Comparison of LabGenomics Co's Piotroski F-Score

For the Diagnostics & Research subindustry, LabGenomics Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LabGenomics Co's Piotroski F-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, LabGenomics Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where LabGenomics Co's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Net Income was -10845.449 + -9007.306 + 226.221 + -2709.471 = ₩-22,336 Mil.
Cash Flow from Operations was 4959.076 + -6651.951 + -1241.476 + -1231.681 = ₩-4,166 Mil.
Revenue was 22019.065 + 19913.348 + 22230.711 + 21653.541 = ₩85,817 Mil.
Gross Profit was 7168.379 + 6400.266 + 8495.777 + 8377.324 = ₩30,442 Mil.
Average Total Assets from the begining of this year (Sep23)
to the end of this year (Sep24) was
(341344.052 + 313457.036 + 307453.441 + 304446.59 + 295293.462) / 5 = ₩312398.9162 Mil.
Total Assets at the begining of this year (Sep23) was ₩341,344 Mil.
Long-Term Debt & Capital Lease Obligation was ₩1,856 Mil.
Total Current Assets was ₩145,578 Mil.
Total Current Liabilities was ₩74,663 Mil.
Net Income was -2036.974 + 4356.985 + 3362.787 + -1548.241 = ₩4,135 Mil.

Revenue was 18740.924 + 14680.291 + 15249.353 + 21177.885 = ₩69,848 Mil.
Gross Profit was 10276.292 + 7909.951 + 8059.681 + 9255.879 = ₩35,502 Mil.
Average Total Assets from the begining of last year (Sep22)
to the end of last year (Sep23) was
(256225.482 + 250652.717 + 316979.38 + 315322.875 + 341344.052) / 5 = ₩296104.9012 Mil.
Total Assets at the begining of last year (Sep22) was ₩256,225 Mil.
Long-Term Debt & Capital Lease Obligation was ₩24,294 Mil.
Total Current Assets was ₩176,329 Mil.
Total Current Liabilities was ₩65,884 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

LabGenomics Co's current Net Income (TTM) was -22,336. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

LabGenomics Co's current Cash Flow from Operations (TTM) was -4,166. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep23)
=-22336.005/341344.052
=-0.06543546

ROA (Last Year)=Net Income/Total Assets (Sep22)
=4134.557/256225.482
=0.0161364

LabGenomics Co's return on assets of this year was -0.06543546. LabGenomics Co's return on assets of last year was 0.0161364. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

LabGenomics Co's current Net Income (TTM) was -22,336. LabGenomics Co's current Cash Flow from Operations (TTM) was -4,166. ==> -4,166 > -22,336 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep23 to Sep24
=1856.305/312398.9162
=0.0059421

Gearing (Last Year: Sep23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep22 to Sep23
=24293.832/296104.9012
=0.08204468

LabGenomics Co's gearing of this year was 0.0059421. LabGenomics Co's gearing of last year was 0.08204468. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep24)=Total Current Assets/Total Current Liabilities
=145578.499/74663.03
=1.94980701

Current Ratio (Last Year: Sep23)=Total Current Assets/Total Current Liabilities
=176329.014/65884.226
=2.67634644

LabGenomics Co's current ratio of this year was 1.94980701. LabGenomics Co's current ratio of last year was 2.67634644. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

LabGenomics Co's number of shares in issue this year was 75.263. LabGenomics Co's number of shares in issue last year was 73.726. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=30441.746/85816.665
=0.35473

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=35501.803/69848.453
=0.50826899

LabGenomics Co's gross margin of this year was 0.35473. LabGenomics Co's gross margin of last year was 0.50826899. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep23)
=85816.665/341344.052
=0.25140812

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep22)
=69848.453/256225.482
=0.27260541

LabGenomics Co's asset turnover of this year was 0.25140812. LabGenomics Co's asset turnover of last year was 0.27260541. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+0+0+0
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

LabGenomics Co has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

LabGenomics Co  (XKRX:084650) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


LabGenomics Co Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of LabGenomics Co's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


LabGenomics Co Business Description

Traded in Other Exchanges
N/A
Address
700 Daewangpangyo-ro, 6F-B, Bundang-gu, Korea Bio Park Building, Gyeonggi-do, Seongnam, KOR, 463-400
LabGenomics Co Ltd is a healthcare company. The Company operates in three business divisions namely NGS, Diagnostic service, IVD products. NGS offers mom guard, cancer panel, Predisposition panel and PGS; Diagnostic service provides esoteric tests such as cancer genetics, genetic disorder. Whereas IVD products include DNA chips, PCR kit among others.

LabGenomics Co Headlines

No Headlines